SURESH SESHAN: Open Payments
NPI 1689937427 · MCCORDSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 47 payments from 14 companies in 2025. Trend: 2023 $66 · 2024 $547 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $212 |
| Amgen Inc. | 7 | $103 |
| Neurocrine BioSciences, Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| PFIZER INC. | 4 | $74 |
| Exact Sciences Corporation | 4 | $68 |
| Astellas Pharma US Inc | 2 | $49 |
| Lilly USA, LLC | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: Ozempic, INGREZZA, Auvelity, Veozah, MOUNJARO, EVENITY, OTEZLA, SHINGRIX.
Industry payments across IN — which companies pay providers there.
